Filing Signals

Source: SEC EDGAR Compiled 2026-11-14 10:32 UTC 23 automated checks passing

← All events

Benitec Biopharma Inc.

CIK 1808898 BNTC·Pharmaceutical Preparations · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K
  2. Auditor change 8-K +118d
Refine

Auditor change SEC item code

Benitec Biopharma Inc. dismissed its auditor and engaged EY

Evidence
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Severity
normal
Source
SEC 8-K item code
Successor auditor
EY
Successor tier
big_four
Why
The company's independent registered accounting firm changed.

Source filing ↗

Auditor change SEC item code

Benitec Biopharma Inc. dismissed its auditor and engaged EY

The company dismissed the auditor. not stated → EY

Evidence
Direction
dismissed
Direction label
The company dismissed the auditor
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Severity
normal
Source
SEC 8-K item code
Successor auditor
EY
Successor tier
big_four
Why
The company's independent registered accounting firm changed.

Source filing ↗

Finance chief departure Filing comparison

Benitec Biopharma Inc.'s Chief Financial Officer departed and a successor was named

Evidence
Interim only
No
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
normal
Source
SEC 8-K item code
Successor named
Yes
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗